NELSON LABS
ActiveSummary
NELSON LABS has been active since 1990 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €595.32M and a net result of €38.07M. Equity is growing by ~37% per year across the filed fiscal years. Its solvency ranks better than 71% of 191 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability61▼-8
Solvency100=
Growth73=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €2M at 30 days acceptable
Liquidity short (current ratio 0.6 against 0.95 in 2024; short-term debt: 22.5% and cash: 3.6% of total assets), and 22.6% of the assets are financed with debt.
Credit check for your own amount and term
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
77.4%
Return on assets
5%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 72
Relative position
BE, all sectors
reference
Scientific research and development (NACE 72)
about 30% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 27-07-2026, 4 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
4 d early
2024
27 d early
2023
30 d late
2022
59 d late
2021
81 d late
2020
151 d late
2019
61 d late
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
25-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, full schema
Turnover
€41.25M▲ 8.3%
2024 · €38.10M
2018: €22.46Mlowest in 8 years
2019: €26.42M▲ +17.6% vs 2018
2020: €22.58M▼ -14.5% vs 2019
2021: €29.61M▲ +31.1% vs 2020
2022: €39.19M▲ +32.4% vs 2021
2023: €38.07M▼ -2.9% vs 2022
2024: €38.10M▲ +0.1% vs 2023
2025: €41.25M▲ +8.3% vs 2024highest in 8 years
2018 → 2025
EBIT margin
38.9%▲ 9.6pp
2024 · 29.2%
2018: 22.0%lowest in 8 years
2019: 26.1%▲ +18.9% vs 2018
2020: 33.2%▲ +26.9% vs 2019
2021: 39.5%▲ +18.9% vs 2020highest in 8 years
2022: 37.9%▼ -4.0% vs 2021
2023: 33.2%▼ -12.5% vs 2022
2024: 29.2%▼ -11.8% vs 2023
2025: 38.9%▲ +32.9% vs 2024
2018 → 2025
Net result
€38.07M▼ 56.6%
2024 · €87.80M
2018: €3.39Mlowest in 8 years
2019: €4.76M▲ +40.1% vs 2018
2020: €5.36M▲ +12.7% vs 2019
2021: €8.82M▲ +64.5% vs 2020
2022: €12.07M▲ +36.9% vs 2021
2023: €8.55M▼ -29.2% vs 2022
2024: €87.80M▲ +927% vs 2023highest in 8 years
2025: €38.07M▼ -56.6% vs 2024
2018 → 2025
Working capital
€-69.15M▼ 699%
2024 · €-8.66M
2018: €8.12M
2019: €12.82M▲ +57.8% vs 2018
2020: €18.17M▲ +41.7% vs 2019
2021: €27.28M▲ +50.2% vs 2020
2022: €37.97M▲ +39.2% vs 2021
2023: €46.27M▲ +21.9% vs 2022highest in 8 years
2024: €-8.66M▼ -119% vs 2023
2025: €-69.15M▼ -699% vs 2024lowest in 8 years
2018 → 2025
Trend over the years
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Turnover€29.61M-€39.19M▲ 32.4%€38.07M▼ 2.9%€38.10M▲ 0.1%€41.25M▲ 8.3%
2021: €29.61Mlowest in 5 years
2022: €39.19M▲ +32.4% vs 2021
2023: €38.07M▼ -2.9% vs 2022
2024: €38.10M▲ +0.1% vs 2023
2025: €41.25M▲ +8.3% vs 2024highest in 5 years
Equity€32.67M-€44.74M▲ 37.0%€53.29M▲ 19.1%€654.84M▲ 1,129%€595.32M▼ 9.1%
2021: €32.67Mlowest in 5 years
2022: €44.74M▲ +37.0% vs 2021
2023: €53.29M▲ +19.1% vs 2022
2024: €654.84M▲ +1129% vs 2023highest in 5 years
2025: €595.32M▼ -9.1% vs 2024
Operating result€11.69M-€14.85M▲ 27.0%€12.63M▼ 15.0%€11.14M▼ 11.8%€16.03M▲ 43.9%
2021: €11.69M
2022: €14.85M▲ +27.0% vs 2021
2023: €12.63M▼ -15.0% vs 2022
2024: €11.14M▼ -11.8% vs 2023lowest in 5 years
2025: €16.03M▲ +43.9% vs 2024highest in 5 years
Net result€8.82M-€12.07M▲ 36.9%€8.55M▼ 29.2%€87.80M▲ 927%€38.07M▼ 56.6%
2021: €8.82M
2022: €12.07M▲ +36.9% vs 2021
2023: €8.55M▼ -29.2% vs 2022lowest in 5 years
2024: €87.80M▲ +927% vs 2023highest in 5 years
2025: €38.07M▼ -56.6% vs 2024
Result per fiscal year
Operating resultNet result
The operating result recovers in 2025; 2025 is 44% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €769.00M
Fixed assets
€664.79M ▲ 0.2%
Current assets
€104.22M ▼ 34.4%
Equity and liabilities €769.00M
Equity
€595.32M ▼ 9.1%
Debt
€173.68M ▲ 3.6%
Debt's share of the balance-sheet total rises from 20.4% to 22.6%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€17.74M▲
2024 · €12.75M
Cash flow
€39.78M▼
2024 · €89.40M
Current ratio
0.60▼
2024 · 0.95
Quick ratio
0.52▼
2024 · 0.90
Debt to equity
0.29▲
2024 · 0.26
ROE
6.4%▼
2024 · 13.4%
ROA
5.0%▼
2024 · 10.7%
Interest coverage
1.93▼
2024 · 2.57
Debt ≤ 1 year
€173.36M▲
2024 · €167.55M
Income taxes
€2.20M▲
2024 · €1.86M
Staff costs
€16.43M▲
2024 · €15.80M
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 76 lines
Balance sheet
Code20242025
Assets
Total assets20/58€822.46M€769.00M▼
Fixed assets21/28€663.56M€664.79M▲
Intangible fixed assets21€1.77M€1.58M▼
Tangible fixed assets22/27€7.02M€8.43M▲
Plant, machinery and equipment23€4.03M€4.76M▲
Furniture and vehicles24€69k€93k▲
Leasing and similar rights25€113k€113k=
Other tangible fixed assets26€726k€1.26M▲
Assets under construction and advance payments27€2.08M€2.21M▲
Financial fixed assets28€654.77M€654.77M=
Affiliated companies280/1€654.77M€654.77M=
Participating interests280€654.77M€654.77M=
Current assets29/58€158.89M€104.22M▼
Stocks and contracts in progress3€8.32M€14.16M▲
Contracts in progress37€8.32M€14.16M▲
Amounts receivable within one year40/41€65.41M€62.01M▼
Trade receivables40€10.19M€7.75M▼
Other amounts receivable41€55.21M€54.26M▼
Cash at bank and in hand54/58€84.94M€27.71M▼
Deferred charges and accrued income490/1€229k€344k▲
Equity and liabilities
Total equity and liabilities10/49€822.46M€769.00M▼
Equity10/15€654.84M€595.32M▼
Contributions10/11€513.88M€513.88M=
Capital10€348k€348k=
Issued capital100€348k€348k=
Outside capital11€513.53M€513.53M=
Share premium1100/10€513.53M€513.53M=
Reserves13€1.94M€1.94M=
Non-distributable reserves130/1€35k€35k=
Legal reserve130€35k€35k=
Distributable reserves133€1.90M€1.90M=
Profit (loss) carried forward14€139.03M€79.51M▼
Amounts payable17/49€167.61M€173.68M▲
Amounts payable within one year42/48€167.55M€173.36M▲
Financial debts43€160.75M€166.54M▲
Other loans439€160.75M€166.54M▲
Trade debts44€1.18M€1.40M▲
Suppliers440/4€1.18M€1.40M▲
Advances received on contracts in progress46€2.27M-
Taxes, remuneration and social security45€3.35M€5.42M▲
Taxes450/3-€1.28M
Remuneration and social security454/9€3.35M€4.13M▲
Accrued charges and deferred income492/3€63k€320k▲
Income statement
Code20242025
Operating income70/76A€39.31M€47.09M▲
Turnover70€38.10M€41.25M▲
Change in stocks of work in progress, finished goods and contracts in progress71€1.20M€5.84M▲
Non-recurring operating income76A€16k€3k▼
Operating charges60/66A€28.17M€31.06M▲
Goods for resale, raw materials and consumables60€3.90M€3.94M▲
Purchases600/8€3.90M€3.94M▲
Services and other goods61€6.57M€8.45M▲
Remuneration, social security and pensions62€15.80M€16.43M▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1.61M€1.71M▲
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€169k€177k▲
Other operating charges640/8€122k€355k▲
Operating profit (loss)9901€11.14M€16.03M▲
Financial income75/76B€83.58M€36.50M▼
Recurring financial income75€83.58M€36.50M▼
Income from financial fixed assets750€83.07M€32.93M▼
Other financial income752/9€513k€3.57M▲
Financial charges65/66B€5.06M€12.26M▲
Recurring financial charges65€5.06M€12.26M▲
Debt charges650€4.95M€9.20M▲
Other financial charges652/9€111k€3.06M▲
Profit (loss) for the period before taxes9903€89.66M€40.27M▼
Income taxes67/77€1.86M€2.20M▲
Taxes670/3€1.86M€2.20M▲
Profit (loss) for the period9904€87.80M€38.07M▼
Profit (loss) for the period to be appropriated9905€87.80M€38.07M▼
Appropriation of the result
Profit (loss) to be appropriated9906€139.05M€177.10M▲
Profit (loss) brought forward from the previous period14P€51.25M€139.03M▲
Transfer to equity691/2€22k-
To the legal reserve6920€22k-
Profit to be distributed694/7-€97.59M
Return on contributions (dividend)694-€97.59M
Social balance
Average headcount (FTE)9087175.4202.5▲
The notes to these accounts (57 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Accounts by statement
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Operating income70/76A | €32.96M | €39.55M | €38.46M | €39.31M | €47.09M | ▲ 19.8% |
| Turnover70 | €29.61M | €39.19M | €38.07M | €38.10M | €41.25M | ▲ 8.3% |
| Change in stocks of work in progress, finished goods and contracts in progress71 | €3.35M | €360k | €-483k | €1.20M | €5.84M | ▲ 388% |
| Own construction capitalised72 | - | - | €313k | - | - | - |
| Non-recurring operating income76A | - | - | €560k | €16k | €3k | ▼ 81.7% |
| Operating charges60/66A | €21.27M | €24.70M | €25.83M | €28.17M | €31.06M | ▲ 10.3% |
| Goods for resale, raw materials and consumables60 | €4.04M | €4.77M | €3.88M | €3.90M | €3.94M | ▲ 0.9% |
| Purchases600/8 | €4.04M | €4.77M | €3.88M | €3.90M | €3.94M | ▲ 0.9% |
| Services and other goods61 | €4.82M | €4.99M | €5.81M | €6.57M | €8.45M | ▲ 28.6% |
| Remuneration, social security and pensions62 | €11.24M | €13.59M | €14.32M | €15.80M | €16.43M | ▲ 4.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €921k | €1.04M | €1.16M | €1.61M | €1.71M | ▲ 6.3% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4 | €2 | - | €-36k | €169k | €177k | ▲ 5.0% |
| Provisions for liabilities and charges: additions (uses and reversals)635/8 | - | - | €-54k | - | - | - |
| Other operating charges640/8 | €247k | €222k | €135k | €122k | €355k | ▲ 191% |
| Non-recurring operating charges66A | - | €94k | €620k | - | - | - |
| Operating profit (loss)9901 | €11.69M | €14.85M | €12.63M | €11.14M | €16.03M | ▲ 43.9% |
| Financial income75/76B | €189k | €747k | €228k | €83.58M | €36.50M | ▼ 56.3% |
| Recurring financial income75 | €189k | €747k | €228k | €83.58M | €36.50M | ▼ 56.3% |
| Income from financial fixed assets750 | - | - | - | €83.07M | €32.93M | ▼ 60.4% |
| Other financial income752/9 | €189k | €747k | €228k | €513k | €3.57M | ▲ 596% |
| Financial charges65/66B | €103k | €411k | €253k | €5.06M | €12.26M | ▲ 142% |
| Recurring financial charges65 | €103k | €411k | €253k | €5.06M | €12.26M | ▲ 142% |
| Debt charges650 | - | - | - | €4.95M | €9.20M | ▲ 85.8% |
| Other financial charges652/9 | €103k | €411k | €253k | €111k | €3.06M | ▲ 2,668% |
| Profit (loss) for the period before taxes9903 | €11.78M | €15.19M | €12.60M | €89.66M | €40.27M | ▼ 55.1% |
| Income taxes67/77 | €2.96M | €3.11M | €4.05M | €1.86M | €2.20M | ▲ 18.3% |
| Taxes670/3 | €2.96M | €3.11M | €4.05M | €1.86M | €2.20M | ▲ 18.3% |
| Profit (loss) for the period9904 | €8.82M | €12.07M | €8.55M | €87.80M | €38.07M | ▼ 56.6% |
| Transfer from tax-exempt reserves789 | - | €517k | - | - | - | - |
| Profit (loss) for the period to be appropriated9905 | €8.82M | €12.59M | €8.55M | €87.80M | €38.07M | ▼ 56.6% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €39.10M | €52.57M | €58.61M | €822.46M | €769.00M | ▼ 6.5% |
| Fixed assets21/28 | €5.48M | €6.97M | €7.21M | €663.56M | €664.79M | ▲ 0.2% |
| Intangible fixed assets21 | €170k | €1.48M | €1.69M | €1.77M | €1.58M | ▼ 10.7% |
| Tangible fixed assets22/27 | €5.31M | €5.49M | €5.52M | €7.02M | €8.43M | ▲ 20.1% |
| Plant, machinery and equipment23 | €2.29M | €2.52M | €3.41M | €4.03M | €4.76M | ▲ 18.1% |
| Furniture and vehicles24 | €117k | €118k | €86k | €69k | €93k | ▲ 35.5% |
| Leasing and similar rights25 | €194k | €113k | €113k | €113k | €113k | = |
| Other tangible fixed assets26 | €342k | €581k | €620k | €726k | €1.26M | ▲ 74.0% |
| Assets under construction and advance payments27 | €2.37M | €2.16M | €1.28M | €2.08M | €2.21M | ▲ 5.9% |
| Financial fixed assets28 | - | - | - | €654.77M | €654.77M | = |
| Affiliated companies280/1 | - | - | - | €654.77M | €654.77M | = |
| Participating interests280 | - | - | - | €654.77M | €654.77M | = |
| Current assets29/58 | €33.62M | €45.60M | €51.41M | €158.89M | €104.22M | ▼ 34.4% |
| Stocks and contracts in progress3 | €7.24M | €7.60M | €7.12M | €8.32M | €14.16M | ▲ 70.2% |
| Contracts in progress37 | €7.24M | €7.60M | €7.12M | €8.32M | €14.16M | ▲ 70.2% |
| Amounts receivable within one year40/41 | €25.27M | €36.63M | €43.71M | €65.41M | €62.01M | ▼ 5.2% |
| Trade receivables40 | €7.32M | €11.04M | €8.16M | €10.19M | €7.75M | ▼ 23.9% |
| Other amounts receivable41 | €17.95M | €25.59M | €35.56M | €55.21M | €54.26M | ▼ 1.7% |
| Cash at bank and in hand54/58 | €880k | €1.05M | €211k | €84.94M | €27.71M | ▼ 67.4% |
| Deferred charges and accrued income490/1 | €233k | €321k | €361k | €229k | €344k | ▲ 50.3% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €39.10M | €52.57M | €58.61M | €822.46M | €769.00M | ▼ 6.5% |
| Equity10/15 | €32.67M | €44.74M | €53.29M | €654.84M | €595.32M | ▼ 9.1% |
| Contributions10/11 | €125k | €125k | €125k | €513.88M | €513.88M | = |
| Capital10 | €125k | €125k | €125k | €348k | €348k | = |
| Issued capital100 | €125k | €125k | €125k | €348k | €348k | = |
| Outside capital11 | - | - | - | €513.53M | €513.53M | = |
| Share premium1100/10 | - | - | - | €513.53M | €513.53M | = |
| Reserves13 | €1.91M | €1.91M | €1.91M | €1.94M | €1.94M | = |
| Non-distributable reserves130/1 | €13k | €13k | €13k | €35k | €35k | = |
| Legal reserve130 | €13k | €13k | €13k | €35k | €35k | = |
| Tax-exempt reserves132 | €517k | - | - | - | - | - |
| Distributable reserves133 | €1.39M | €1.90M | €1.90M | €1.90M | €1.90M | = |
| Profit (loss) carried forward14 | €30.63M | €42.70M | €51.25M | €139.03M | €79.51M | ▼ 42.8% |
| Provisions and deferred taxes16 | €54k | €54k | €0 | - | - | - |
| Provisions for liabilities and charges160/5 | €54k | €54k | €0 | - | - | - |
| Other liabilities and charges164/5 | €54k | €54k | €0 | - | - | - |
| Amounts payable17/49 | €6.38M | €7.77M | €5.32M | €167.61M | €173.68M | ▲ 3.6% |
| Amounts payable within one year42/48 | €6.34M | €7.63M | €5.14M | €167.55M | €173.36M | ▲ 3.5% |
| Financial debts43 | - | - | - | €160.75M | €166.54M | ▲ 3.6% |
| Other loans439 | - | - | - | €160.75M | €166.54M | ▲ 3.6% |
| Trade debts44 | €1.57M | €1.47M | €1.05M | €1.18M | €1.40M | ▲ 19.2% |
| Suppliers440/4 | €1.57M | €1.47M | €1.05M | €1.18M | €1.40M | ▲ 19.2% |
| Advances received on contracts in progress46 | €1.28M | €2.08M | €1.32M | €2.27M | - | - |
| Taxes, remuneration and social security45 | €3.49M | €4.08M | €2.77M | €3.35M | €5.42M | ▲ 61.5% |
| Taxes450/3 | €161k | €283k | - | - | €1.28M | - |
| Remuneration and social security454/9 | €3.33M | €3.80M | €2.77M | €3.35M | €4.13M | ▲ 23.2% |
| Accrued charges and deferred income492/3 | €42k | €140k | €183k | €63k | €320k | ▲ 409% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €8.82M | €12.07M | €8.55M | €87.80M | €38.07M | ▼ 56.6% |
| + Depreciation and write-downs630 | €921k | €1.04M | €1.16M | €1.61M | €1.71M | ▲ 6.3% |
| Operating cash flow (approximation) | €9.74M | €13.11M | €9.71M | €89.40M | €39.78M | ▼ 55.5% |
| Investment in fixed assets (approximation) | - | €-2.52M | €-1.40M | €-657.96M | €-2.93M | ▲ 99.6% |
| Change in cash | - | €169k | €-838k | €84.73M | €-57.24M | ▼ 168% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
10-08
State Gazette act
Resignations: GARA (director) and Riaz Amirali BANDALI (director)Appointments: GARA (director) and Riaz Amirali BANDALI (director) · Permanent representative: Kurt Marcel Ursula PEETERS · Legal-form conversion13 facts ▸
State Gazette act
Resignations: GARA (director) and Riaz Amirali BANDALI (director)
Appointments: GARA (director) and Riaz Amirali BANDALI (director) · Permanent representative: Kurt Marcel Ursula PEETERS · Legal-form conversion13 facts ▸
- General meeting, 23-07-2026
- Legal-form conversion, Naamloze vennootschap -> Besloten vennootschap
- Net-asset statement, 31-05-2026
- Director resignation, GARA (director)
- Director resignation, Riaz Amirali BANDALI (director)
- Director appointment, GARA (director)
- Director appointment, Riaz Amirali BANDALI (director)
- Permanent representative, Kurt Marcel Ursula PEETERS
- Mandate compensation, GARA
- Mandate compensation, Riaz Amirali BANDALI
- Power of attorney, BERQUIN NOTARISSEN
- Shares issued, 278
- +1 further facts in this act
04-08
State Gazette act
Resignation: Joseph Shrawder (director)Appointment: Riaz Amirali Bandali (director) · Power of attorney7 facts ▸
State Gazette act
Resignation: Joseph Shrawder (director)
Appointment: Riaz Amirali Bandali (director) · Power of attorney7 facts ▸
- General meeting, 30/06/2026
- Director resignation, Joseph Shrawder (director)
- Director appointment, Riaz Amirali Bandali (director)
- Power of attorney, Susana Gonzalez Melon
- Power of attorney, Hannelore De Bie
- Power of attorney, Dries Remeysen
- Power of attorney, Allen Overy Shearman Sterling (Belgium) LLP
27-07
NBB filing
Annual accounts filed
fiscal year 2025 · full schema
2025
04-07
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
2024
31-12
Financial
Highest result since 2018net €87.80M ▲927%
Net result €87.80M, the highest in the series.
31-12
Financial
Equity above €500MEq €654.84M ▲1,129%
7 profitable years in a row build equity to €654.84M.
30-08
NBB filing
Annual accounts filed
fiscal year 2023 · full schema · 30 days late
2023
31-12
Financial
Equity above €50MEq €53.29M ▲19.1%
6 profitable years in a row build equity to €53.29M.
28-09
NBB filing
Annual accounts filed
fiscal year 2022 · full schema · 59 days late
2022
20-10
NBB filing
Annual accounts filed
fiscal year 2021 · full schema · 81 days late
2021
31-12
Financial
Equity above €25MEq €32.67M ▲37%
4 profitable years in a row build equity to €32.67M.
29-12
NBB filing
Annual accounts filed
fiscal year 2020 · full schema · 151 days late
Show earlier events
2020
30-09
NBB filing
Annual accounts filed
fiscal year 2019 · full schema · 61 days late
2019
08-07
NBB filing
Annual accounts filed
fiscal year 2018 · full schema
2018
14-06
NBB filing
Annual accounts filed
fiscal year 2017 · full schema
2017
14-06
NBB filing
Annual accounts filed
fiscal year 2016 · full schema
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
2 of 18 acts read
About the unread acts
Of the 18 Belgian State Gazette acts we know for this company, 2 have been read. The other 16 have not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
2 directors, last change in 2026
GARA
CurrentDirector · since 23-07-2026 · Private limited company · perm. rep.: Kurt Marcel Ursula PEETERS
Riaz Amirali BANDALI
CurrentDirector · since 23-07-2026
23-07-2026
GARA: Reappointed as Director
23-07-2026
Riaz Amirali BANDALI: Reappointed as Director
30-06-2026
Riaz Amirali BANDALI: Appointed as Director
30-06-2026
Joseph Shrawder: Resigned as Director
Not every act has been read: a resignation may be missing here
16 of this company's 18 Belgian State Gazette acts have not been read yet. Appointments and resignations recorded in them are missing above: a director who resigned there may therefore still show here as sitting. The acts are in the Timeline.
Location & real-estate footprint
Registered office, Leuven · 1 establishment unit since 1991
Ground area
1.0 ha
Building footprint
1,691 m²
Volume, LiDAR
19,452 m³
Parcel 24514C0093/00W000, Flanders · tallest building 13.7 m, ±4 floors. Linked by address, not a title deed.
2
companies at this address
See who is registered here
1 establishment unit
TOXIKON EUROPE NV
since 19912.051.016.696
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 24514C0093/00W000 | Flanders | 1.0 ha | 1 · 1,691 m² | 13.7 m · 4 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Articles of association
Purpose
De vennootschap heeft tot voorwerp in België en in het buitenland multidisciplinaire toxicologische en milieu- onderzoekingen en testen te verrichten, gericht op de evaluatie van…
Full purpose
De vennootschap heeft tot voorwerp in België en in het buitenland multidisciplinaire toxicologische en milieu- onderzoekingen en testen te verrichten, gericht op de evaluatie van de effecten van producten en procedés op de menselijke gezondheid en op het milieu. De vennootschap zal daartoe de nodige laboratoria, studiecentra en kantoren organiseren, oprichten en betrekken. De vennootschap zal analyses maken, adviesactiviteiten ontwikkelen en rapporten leveren aan milieu-ingenieurs en aan de industrie en zich in het bijzonder bezighouden met scheikunde, ecotoxicologie, zoogdieren-toxicologie, in- vitro en alternatieve toxicologie, genetische, water- en luchttoxicologie. Deze activiteiten zullen omvatten, doch niet beperkt zijn tot 1. water- en luchttoxicologie 2. effectenrapportering 3. bioremediatie 4. wetenschappelijk onderzoek op het gebied van pesticide-, herbicide- en insecticideregistraties 5. wetenschappelijke en technische raadgevingen 6. biomedisch onderzoek en -ontwikkeling 7. in—vivo en in-vitro toxicologie. De vennootschap mag alle vormen van toegepast wetenschappelijk onderzoek doen van nieuwe procedés of nieuwe producten, evenals alle brevetten, merken, licenties, tekeningen en modellen, op punt stellen en commercialiseren. De vennootschap mag ook zelf licenties nemen. De vennootschap mag, in het algemeen, alle mogelijke commerciële, industriële, financiële, roerende of onroerende operaties doorvoeren, die direct of indirect verband houden met haar voorwerp of die van aard zouden zijn de verwezenlijking ervan te vergemakkelijken of te bevorderen. Zij kan zich door alle middelen inmengen in alle zaken, ondernemingen of vennootschappen die eenzelfde, gelijkaardig of aanverwant voorwerp hebben of die van aard zijn om de ontwikkeling van haar onderneming te bevorderen. De vennootschap mag eveneens aandelen hebben in een andere vennootschap, mag als raadgever optreden met betrekking tot dezelfde, gelijkaardig of aanverwante zaken en mag tussenkomen in het management. De Organisatie en de coördinatie van elke andere vennootschap die eenzelfde, analoog, gelijkaardig of aanverwant voorwerp hebben, zowel in België als in het buitenland. De vennootschap kan haar activiteiten hetzij voor eigen rekening, hetzij bij deelname met derden, hetzij voor rekening van derden verrichten. De vennootschap mag, door middel van inbreng, fusie, onderschrijving of elke andere wijzen inmengen in alle ondernemingen, verenigingen of vennootschappen die eenzelfde, gelijkaardig of aanverwant voorwerp hebben of die van aard zijn om de ontwikkeling van haar activiteit te bevorderen. De vennootschap mag haar voorwerp realiseren op om het even welke plaats, op om het even welke manier en met die middelen die haar het meest geschikt lijken.
Structure & network
Public money · subsidies and aid
Flemish government
2022 to 2025 · 5 entries · 29,906 EUR awarded · 29,906 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2025 | 2 | 7,002 EUR | 7,002 EUR |
| 2024 | 1 | 7,562 EUR | 7,562 EUR |
| 2023 | 1 | 8,739 EUR | 8,739 EUR |
| 2022 | 1 | 6,603 EUR | 6,603 EUR |
Schemes
Vlaams opleidingsverlof (VOV)
Individueel Maatwerk
Recognitions · licences · registrations
Legal Entity Identifier
894500R99IWJHGVJWP70
Similar companies · same sector, comparable size
United Beet Seeds
BE 1005.997.787
Tienen · Eq €659.41M
Interuniversitair Micro-Electronica Centrum
BE 0425.260.668
Leuven · Eq €512.12M
ABLYNX
BE 0475.295.446
Gent · Eq €355.52M
MYRRHA
BE 0778.714.119
Brussel · Eq €301.13M
OMEGA PHARMA INNOVATION & DEVELOPMENT
BE 0884.084.724
Gent · Eq €240.23M
Of 1,177 companies in sector 72109 we hold annual accounts for 716. 20 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded28-12-1990
Fiscal year end31-12
Activities, NACEBEL 2025
71121Engineering and related technical consultancy, excluding land surveyors
72109Other research and development on natural sciences
Scores and ratios are computed by Checked and are not a credit decision.